These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 175675)

  • 1. Experience with twice-a-day fractionation in clinical radiotherapy.
    Shukovsky LJ; Fletcher GH; Montague ED; Withers HR
    AJR Am J Roentgenol; 1976 Jan; 126(1):155-62. PubMed ID: 175675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
    Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Local control after the use of adjuvant electron beam intraoperative radiotherapy in patients with high-risk head and neck cancer: the UCSF experience.
    Ling SM; Roach M; Fu KK; Coleman C; Chan A; Singer M
    Cancer J Sci Am; 1996; 2(6):321-9. PubMed ID: 9166552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant radiotherapy after transoral laser microsurgery for advanced squamous carcinoma of the head and neck.
    Pradier O; Christiansen H; Schmidberger H; Martin A; Jäckel MC; Steiner W; Ambrosch P; Kahler E; Hess CF
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1368-77. PubMed ID: 16169679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of hyperfractionation and conventional fractionation radiotherapy with concurrent docetaxel, cisplatin and 5-fluorouracil (TPF) chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN).
    Katori H; Tsukuda M; Watai K
    Cancer Chemother Pharmacol; 2007 Aug; 60(3):399-406. PubMed ID: 17096160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Different trends of optimal fractionation schedule according to stage in treatment of differentiated squamous cell carcinoma of the head and neck (author's transl)].
    Sugawara T; Tanaka O; Iguchi H; Aihara T
    Nihon Igaku Hoshasen Gakkai Zasshi; 1982 Mar; 42(3):271-80. PubMed ID: 7110929
    [No Abstract]   [Full Text] [Related]  

  • 7. Carboplatin and radiotherapy in the treatment of head and neck cancer: six years' experience.
    Zamboglou N; Schnabel T; Kolotas C; Achterrath W; Strehl H; Dalhäuser S; Vogt HG; Lenaz L; Schmitt G
    Semin Oncol; 1994 Oct; 21(5 Suppl 12):45-53. PubMed ID: 7992066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting the effect of accelerated fractionation in postoperative radiotherapy for head and neck cancer based on molecular marker profiles: data from a randomized clinical trial.
    Suwinski R; Jaworska M; Nikiel B; Grzegorz W; Bankowska-Wozniak M; Wojciech M; Krzysztof S; Dariusz L
    Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):438-46. PubMed ID: 19733016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized phase I/II trial of two variants of accelerated fractionated radiotherapy regimens for advanced head and neck cancer: results of RTOG 88-09.
    Fu KK; Clery M; Ang KK; Byhardt RW; Maor MH; Beitler JJ
    Int J Radiat Oncol Biol Phys; 1995 Jun; 32(3):589-97. PubMed ID: 7790243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiation therapy for advanced head and neck squamous-cell carcinoma using twice-a-day fractionation.
    Medini E; Rao Y; Kim T; Jones TK; Levitt SH
    Radiology; 1980 Feb; 134(2):531-2. PubMed ID: 7352244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of tumor-recurrence times.
    Suit H; Wette R; Lindberg R
    Radiology; 1967 Feb; 88(2):311-21 passim. PubMed ID: 6066746
    [No Abstract]   [Full Text] [Related]  

  • 12. Outcomes after radiotherapy for basaloid squamous cell carcinoma of the head and neck: a case-control study.
    Thariat J; Ahamad A; El-Naggar AK; Williams MD; Holsinger FC; Glisson BS; Allen PK; Morrison WH; Weber RS; Ang KK; Garden AS
    Cancer; 2008 Jun; 112(12):2698-709. PubMed ID: 18429002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular marker profiles predict locoregional control of head and neck squamous cell carcinoma in a randomized trial of continuous hyperfractionated accelerated radiotherapy.
    Buffa FM; Bentzen SM; Daley FM; Dische S; Saunders MI; Richman PI; Wilson GD
    Clin Cancer Res; 2004 Jun; 10(11):3745-54. PubMed ID: 15173081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Boron neutron capture therapy in the treatment of locally recurred head-and-neck cancer: final analysis of a phase I/II trial.
    Kankaanranta L; Seppälä T; Koivunoro H; Saarilahti K; Atula T; Collan J; Salli E; Kortesniemi M; Uusi-Simola J; Välimäki P; Mäkitie A; Seppänen M; Minn H; Revitzer H; Kouri M; Kotiluoto P; Seren T; Auterinen I; Savolainen S; Joensuu H
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):e67-75. PubMed ID: 21300462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salvage surgery after failure of very accelerated radiotherapy in advanced head-and-neck squamous cell carcinoma.
    Temam S; Pape E; Janot F; Wibault P; Julieron M; Lusinchi A; Mamelle G; Marandas P; Luboinski B; Bourhis J
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1078-83. PubMed ID: 15990011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concomitant cisplatin significantly improves locoregional control in advanced head and neck cancers treated with hyperfractionated radiotherapy.
    Huguenin P; Beer KT; Allal A; Rufibach K; Friedli C; Davis JB; Pestalozzi B; Schmid S; Thöni A; Ozsahin M; Bernier J; Töpfer M; Kann R; Meier UR; Thum P; Bieri S; Notter M; Lombriser N; Glanzmann C
    J Clin Oncol; 2004 Dec; 22(23):4665-73. PubMed ID: 15534360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.
    Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative hyperfractionated accelerated radiotherapy and radical surgery in advanced head and neck cancer: a prospective phase II study.
    Lindholm P; Valavaara R; Aitasalo K; Kulmala J; Laine J; Elomaa L; Sillanmäki L; Minn H; Grénman R
    Radiother Oncol; 2006 Feb; 78(2):146-51. PubMed ID: 16307813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment results on advanced neck metastasis (N3) from head and neck squamous carcinoma.
    Carvalho AL; Kowalski LP; Agra IM; Pontes E; Campos OD; Pellizzon AC
    Otolaryngol Head Neck Surg; 2005 Jun; 132(6):862-8. PubMed ID: 15944556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperfractionated accelerated chemoradiation with concurrent fluorouracil-mitomycin is more effective than dose-escalated hyperfractionated accelerated radiation therapy alone in locally advanced head and neck cancer: final results of the radiotherapy cooperative clinical trials group of the German Cancer Society 95-06 Prospective Randomized Trial.
    Budach V; Stuschke M; Budach W; Baumann M; Geismar D; Grabenbauer G; Lammert I; Jahnke K; Stueben G; Herrmann T; Bamberg M; Wust P; Hinkelbein W; Wernecke KD
    J Clin Oncol; 2005 Feb; 23(6):1125-35. PubMed ID: 15718308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.